A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K21.4 KBARGOS THERAPEUTICS INCMay 3, 4:10 PM ET·0001171843-19-002921
- SC 13D/A108.3 KBARGOS THERAPEUTICS INCFeb 14, 11:47 AM ET·0001193125-19-039807
- 8-K18.8 KBARGOS THERAPEUTICS INCDec 3, 8:01 AM ET·0001171843-18-008263
- 10-Q5.7 MBARGOS THERAPEUTICS INCNov 19, 3:13 PM ET·0001171843-18-008023
- 10-Q5.4 MBARGOS THERAPEUTICS INCAug 20, 4:55 PM ET·0001171843-18-006192
- 8-K17.7 KBARGOS THERAPEUTICS INCJul 20, 4:30 PM ET·0001171843-18-005272
- 10-Q5.4 MBARGOS THERAPEUTICS INCMay 15, 4:47 PM ET·0001171843-18-003973
- 8-K18.0 KBARGOS THERAPEUTICS INCApr 24, 5:29 PM ET·0001171843-18-003007
- 8-K21.0 KBARGOS THERAPEUTICS INCApr 19, 8:05 AM ET·0001171843-18-002839
- 10-K10.4 MBARGOS THERAPEUTICS INCApr 2, 2:13 PM ET·0001171843-18-002425
Insiders
10- Abbey Jeffrey DDirector, Chief Executive Officer
- ALLEN LEE F MD PhDChief Medical Officer
- Birner HubertDirector
- Carey RobertDirector
- Harrelson Lori R.Vice President Finance
- Katz Richard DVP & Chief Financial Officer
- MORRISON RICHARD GDirector
- Nicolette Charles A.Chief Science Officer
- Pharmstandard International S.A.10% Owner
- SNYDERMAN RALPHDirector
Tickers
No tickers on record
Addresses
business
4233 TECHNOLOGY DR
DURHAM, NC, 27704
mailing
4233 TECHNOLOGY DR
DURHAM, NC, 27704
Former Names
- MERIX BIOSCIENCE INC2004-10-12